CIRS - The Centre for Innovation in Regulatory Science

Slide of the Month

Median submission gap, median approval time and percentage approved as expedited for new active substances approved by six authorities 2008-2012 compared with 2013-2017.

Slide of the Month Archive >

CIRS NEWS

CIRS Senior Research Analyst Magda Bujar wins Margaret K B Day Prize

CONTACT US

Our People

MEMBER LOGIN

Members have access to:
• Past Workshop Slides
• Atlas
and much more.
Login to our CIRS Member’s Section

CIRS 2018 AGENDA

Download the CIRS 2018 Agenda

Where to meet us

DIA 2018; 24-28 June 2018; Boston Mass, US

READ

Our most recent publications

CIRS R&D Briefing 67 New drug approvals in six major authorities 2008 -2017: Focus on the availability of medicines and company

Liberti L. The practical application of regulatory science: Impact on regulatory policy and practice. Reg Rapporteur. 2018; 15:3-5-9.

Mashaki Ceyhan E, Gürsöz H, Alkan A, Coşkun H, Koyuncu O, Walker S. The Turkish Medicines and Medical Devices Agency: Comparison of its registration process with Australia, Canada, Saudi Arabia, and Singapore. Front Pharmacol. 2018;9 DOI=10.3389/fphar.2018.

Walker S, McAuslane N, Bujar M, Connelly P, Liberti L. Quality decision-making practices: Their application and impact in the development, review and reimbursement of medicines. Netherlands: Off Page, 2017.